Verisk Analytics (VRSK) Share Price Target Raised to $320 – Verisk Analytics (NASDAQ: VRSK): Many investors and analysts are now paying attention to VRSK after revised price forecasts were published. VRSK stock is around $303.65 at present, and given its smart positioning and solid financial results, major platforms and analysts see further upside for the company.
Market confidence supports UBS’s move to lift Verisk Analytics Share price target
May 12, 2025, saw UBS analyst Alex Kramm change his price target for Verisk Analytics from $295 to $320. The updated figure boosts Verisk’s target by 8.47%, showing analysts now believe in the company’s potential for stronger growth. UBS’s ongoing ‘Neutral’ rating didn’t stop the firm from recognizing that Verisk could move upward slightly compared to the overall market.
This target from UBS is one of several from analysts, all of whom are generally optimistic about how the stock will perform over the next year. With data from GuruFocus, it is shown that 15 analysts predict VRSK shares will trade between $232.37 and $340.00, giving an average target of $304.96. As a result, the average upside is 0.43%, which shows that analysts expect modest, positive growth in the short term.
TipRanks Forecast: Moderate Buy with $322.73 Target
TipRanks’ data further reinforces market optimism. Based on 12 analysts’ inputs over the past three months, Verisk holds a “Moderate Buy” consensus rating. The average 12-month price target is $322.73, suggesting a 6.28% upside from the current level.
Verisk Analytics share price target range from a low of $280 to a high of $395, reflecting differing views on the company’s valuation and growth potential. Importantly, several top-performing analysts, including Andrew Steinerman of J.P. Morgan, who has a 92% success rate on VRSK recommendations have reiterated buy ratings with historical profitability on such calls.
In the latest round of ratings, 6 analysts issued a “Buy,” 5 maintained a “Hold,” and only 1 advised a “Sell.” This mixed but positive consensus highlights a broadly supportive view of Verisk’s fundamentals while acknowledging potential market risks and valuation constraints.
Financial Outlook and Earnings Performance
Verisk is still on the course of meeting earnings expectations. The expectation of analysts for next quarter’s EPS is $1.74-1.81, with consensus at $1.7. In the past 12 months, the company has bested EPS estimates every single time, a sure record of the reliability of that company’s earnings.
Projections have the revenue of the next quarter at $763 million to $772 million, with the mean projection settling at $768 million. 75% of the last 12 quarters ticked above revenue expectations for Verisk, cementing a financial trustworthiness in the data analytics field.
Valuation and Industry Position
For the price at which Verisk is likely to trade, the model from GuruFocus’s GF Value puts it at $310.30, a potential 2.19% negotiation from today’s price. The GF Value, through which past and future elements are integrated, being close to the stock price at present is an indication of fairness and not overvaluation.
Verisk is, however, a specialty in analytics and risk management that is gaining ground in need by firms in insurance, finance, and energy corporations. Since digital changes and regulations continue to broaden, the demand for correct information, the central business of Verisk, is likely to remain high.
Conclusion: Gradual Growth with Stable Outlook
Verisk Analytics is a strong performer that maintains a track record of growth in both earnings and revenue. Although analysts depict its price appreciation possibilities as modest, its price target revisions in an upward direction, outstanding financials, and current analyst consensus indicate that VRSK is still a good buy for medium- to long-term investments.
If you are either a conservative investor searching for stability or a market voyeur looking to track sector trends on analysis, Verisk’s moderate but trustworthy upturn is an alluring story in a market environment where turbulence is the new normal.
